獸用抗生素/抗生素市場規模、佔有率、成長分析，按類型、按交付、按動物、按地區 - 行業預測，2025-2032

2023年獸用抗生素和抗菌藥物市場規模為46.2億美元，從2024年的47.8億美元成長到2032年的63億美元，並且預計在預測期內（2025-2032年）將會成長。率為3.5%。

截至2023年10月，全球獸用抗生素和抗菌藥物市場對動物用藥品產業至關重要，這主要是由動物性蛋白質需求激增所推動的。世界人口的成長和可支配收入的增加導致肉類、牛奶和雞蛋的消費量增加，從而導致畜牧業產量增加。這種成長需要使用抗生素和抗菌劑來預防和治療牲畜傳染病。此外，呼吸道和胃腸道感染疾病感染疾病盛行率的上升強調了有效疾病管理的必要性。人們對動物福利和預防通用感染疾病傳播的興趣日益濃厚，進一步強調了這些藥物在確保動物健康、最佳生長和生產力方面的重要性。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析

獸用抗生素/抗菌藥物市場規模：依類型

• 市場概況
• 四環黴素
• 青黴素
• 磺胺類藥物
• 大環內酯
• Aminoglycosides
• 林可醯胺
• Fluoroquinolones
• 頭孢菌素
• 其他抗菌劑和抗生素

按交付量分類的獸用抗生素/抗菌藥物市場規模

• 市場概況
• 預混合料
• 口服粉劑
• 口服液
• 注射
• 其他

獸用抗生素/抗菌藥物市場規模：依動物分類

• 市場概況
• 食用動物
  • 牛
  • 豬
  • 家禽
  • 綿羊和山羊
  • 其他食用動物
• 伴同性動物
  • 狗
  • 貓
  • 馬
  • 其他寵物

獸用抗生素/抗菌藥物市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
• 收益與前一年同期比較（2022-2024）

主要企業簡介

• Zoetis Inc.（USA）
• Merck & Co., Inc.（USA）
• Elanco Animal Health Incorporated（USA）
• Boehringer Ingelheim International GmbH（Germany）
• Ceva Sante Animale（France）
• Virbac（France）
• Vetoquinol（France）
• Bayer AG（Germany）
• Novartis AG（Switzerland）
• Eli Lilly and Company（USA）
• Sanofi（France）
• Intervet Inc.（Netherlands）
• Alltech（Ireland）
• Huvepharma（Bulgaria）
• Kemin Industries（USA）
• Novus International（USA）
• Biomin Holding GmbH（Austria）
• ADM Animal Nutrition（USA）
• Adisseo（France）
• DSM（Netherlands）

結論和建議

Animal Antibiotics and Antimicrobials Market size was valued at USD 4.62 Billion in 2023 and is poised to grow from USD 4.78 Billion in 2024 to USD 6.3 Billion by 2032, growing at a CAGR of 3.5% during the forecast period (2025-2032).

As of October 2023, the global animal antibiotics and antimicrobials market is crucial to the veterinary pharmaceutical sector, primarily driven by the surging demand for animal protein. The increase in the global population and growing disposable incomes has led to higher consumption of meat, milk, and eggs, consequently boosting livestock production. This growth necessitates the use of antibiotics and antimicrobials for the prevention and treatment of infectious diseases among animals. Additionally, the rising prevalence of conditions such as respiratory and gastrointestinal infections emphasizes the need for effective disease management. The heightened focus on animal welfare and the prevention of zoonotic disease transmission further underscores the importance of these pharmaceuticals in ensuring animal health, optimal growth, and productivity.

Top-down and bottom-up approaches were used to estimate and validate the size of the Animal Antibiotics And Antimicrobials market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Animal Antibiotics And Antimicrobials Market Segmental Analysis

Global Animal Antibiotics And Antimicrobials Market is segmented by type, delivery, animal and region. Based on type, the market is segmented into tetracyclines, penicillins, sulfonamides, macrolides, aminoglycosides, lincosamides, fluoroquinolones, cephalosporins and other antimicrobials and antibiotics. Based on delivery, the market is segmented into premixes, oral powder, oral solution, injection and others. Based on animal, the market is segmented into food-producing animals and companion animals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Animal Antibiotics And Antimicrobials Market

The Animal Antibiotics and Antimicrobials market is significantly driven by the emergence of infectious diseases in livestock, including avian influenza, foot-and-mouth disease, and swine fever. These outbreaks highlight the critical need for effective antibiotics and antimicrobials to manage and prevent disease proliferation. The potential economic fallout from such epidemics spurs increased demand for these products, especially in areas where these diseases are frequently encountered. This demand is primarily fueled by the urgent need to safeguard animal health and ensure sustained productivity within the livestock sector, making these pharmaceuticals essential for maintaining the integrity of animal farming operations.

Restraints in the Animal Antibiotics And Antimicrobials Market

The Animal Antibiotics and Antimicrobials market faces significant restraints due to changing consumer preferences towards antibiotic-free products. As awareness around food safety and sustainability continues to grow, there is a rising demand for animal products that do not involve the use of antibiotics. This shift in consumer behavior has prompted producers to transition toward antibiotic-free production methods, negatively affecting the demand for traditional animal antibiotics and antimicrobials. In their efforts to align with market trends and meet consumer expectations, producers are increasingly exploring alternative strategies for disease prevention and growth promotion in livestock, emphasizing sustainability and the reduction of antibiotic use.

Market Trends of the Animal Antibiotics And Antimicrobials Market

The Animal Antibiotics and Antimicrobials market is witnessing a significant trend towards the adoption of antibiotic alternatives, fueled by growing concerns over antimicrobial resistance (AMR) and its implications for both animal and human health. Regulatory pressures, heightened consumer awareness, and industry initiatives are driving the reduction of traditional antibiotic use in livestock production. Consequently, alternatives such as probiotics, prebiotics, phytogenics, and vaccines are emerging as effective solutions to promote animal well-being while minimizing AMR risks. This shift reflects a broader commitment within the industry to enhance animal health, optimize production efficiency, and adhere to responsible usage practices in veterinary medicine, shaping the future of the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Animal Antibiotics And Antimicrobials Market Size by Type & CAGR (2025-2032)

• Market Overview
• Tetracyclines
• Penicillins
• Sulfonamides
• Macrolides
• Aminoglycosides
• Lincosamides
• Fluoroquinolones
• Cephalosporins
• Other Antimicrobials And Antibiotics

Global Animal Antibiotics And Antimicrobials Market Size by Delivery & CAGR (2025-2032)

• Market Overview
• Premixes
• Oral Powder
• Oral Solution
• Injection
• Others

Global Animal Antibiotics And Antimicrobials Market Size by Animal & CAGR (2025-2032)

• Market Overview
• Food-Producing Animals
  • Cattle
  • Pigs
  • Poultry
  • Sheep And Goats
  • Other Food-Producing Animals
• Companion Animals
  • Dogs
  • Cats
  • Horses
  • Other Companion Animals

Global Animal Antibiotics And Antimicrobials Market Size & CAGR (2025-2032)

• North America (Type, Delivery, Animal)
  • US
  • Canada
• Europe (Type, Delivery, Animal)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Delivery, Animal)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Delivery, Animal)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Delivery, Animal)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
• Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Zoetis Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intervet Inc. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alltech (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Huvepharma (Bulgaria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kemin Industries (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novus International (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomin Holding GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ADM Animal Nutrition (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Adisseo (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DSM (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations